About
TVM Capital Life Science Venture Capital is dedicated to funding life science innovations with the potential to transform medical practice. The firm engages deeply with portfolio companies, leveraging a unique twopronged investment strategy. This includes financing innovative early stage therapeutics through a single asset company approach in partnership with Eli Lilly and Company, as Theyll as investing in differentiated commercialstage medtech, diagnostics, Digitalhealth products, and late stage therapeutics. With a significant track record and over 100 years of combined industry expertise, TVM supports the development and market introduction of groundbreaking medical products.